GlaxoSmithKline

Fda Approves 3 Drugs For The Switch From Prescription To Over The Counter

The Food and Drug Administration approved three drugs on Friday to switch from prescription status to being available over the counter: GlaxoSmithKline's (NYSE: GSK) Voltaren Arthritis Pain and two related allergy drugs from Alcon (NYSE: ALC).The...
Related topics: Food And Drug Administration, Arthritis, Allergies

Read More →

Glaxosmithkline Cutting Up To 720 Jobs At European Vaccine Facility

In advance of its split into two companies, pharmaceutical giant GlaxoSmithKline (NYSE: GSK) announced it will cut as many as 720 workers from its vaccine production facility in Belgium. In addition to these layoffs, which are part of its two-year...
Related topics: Vaccines

Read More →

Drugmakers Are Dusting Off Their Ebola Playbooks As They Race To Develop Coronavirus Treatments And...

As the coronavirus outbreak has exploded into a global public-health emergency, leading drugmakers have begun researching treatments and vaccines to stop the virus.  In recent days, Johnson & Johnson, Regeneron Pharmaceuticals, GlaxoSmithKline,...
Related topics: Ebola, Vaccines, Virus, Virology

Read More →

Production Of Two Excedrin Painkillers Halted

WEDNESDAY, Jan. 22, 2020 -- Production and distribution of Excedrin Extra Strength and Excedrin Migraine products have been temporarily stopped, maker GlaxoSmithKline said Tuesday. "Through routine quality control and assurance measures, we...
Related topics: Painkillers, Migraine

Read More →

Drug Maker Temporarily Discontinues Two Popular Migraine Relief Drugs

Pharmaceutical company GlaxoSmithKline announced it is temporarily discontinuing two types of Excedrin migraine medications.  Read more...
Related topics: Migraine

Read More →

Merck's Keytruda Misses One Of Two Goals In Lung Cancer Study

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report GlaxoSmithKline plc (GSK): Free...
Related topics: Merck & Co, Lung Cancer, Cancer, Oncology, Medical Research

Read More →

Astrazeneca Gets Fda Nod For New Breast Cancer Drug Enhertu

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report AstraZeneca PLC (AZN): Free...
Related topics: Astrazeneca, Food And Drug Administration, Breast Cancer, Cancer, Oncology, Medical Research

Read More →

Myriad Genetics Presents Trial Outcomes In Breast Health

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report Haemonetics Corporation (HAE):...
Related topics: Genetics, Medical Research

Read More →

Lilly Initiates Phase Iii Lung Cancer Study On Ret Inhibitor

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report Eli Lilly and Company (LLY):...
Related topics: Lung Cancer, Cancer, Oncology, Medical Research

Read More →

Roche's (rhhby) Sbla For Asthma Drug Xolair Accepted By Fda

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS): Free Stock Analysis Report GlaxoSmithKline plc (GSK): Free Stock...
Related topics: Asthma, Food And Drug Administration, Medical Research, Novartis

Read More →

Glaxo's Asthma Drug Nucala Gets Fda Nod For Pediatric Use

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report AstraZeneca PLC (AZN): Free...
Related topics: Asthma, Food And Drug Administration, Medical Research, Astrazeneca

Read More →

Using A Phosphine Oxide Catalyst To Make Nucleophilic Substitution Reactions Of Alcohols Greener

A team of researchers with the University of Nottingham, Jealott's Hill International Research Centre and the GlaxoSmithKline, Medicines Research Centre, has found a way to use a phosphine oxide catalyst to make nucleophilic substitution reactions...
Related topics: Medical Research

Read More →

Ionis (ions) Out-licenses Hepatitis B Virus Program To Glaxo

Ionis Pharmaceuticals, Inc. IONS announced that it has out-licensed its antisense medicine candidates for treating patients with chronic hepatitis B (CHB) virus infection to pharma giant GlaxoSmithKline plc GSK. Following positive phase II results,...
Related topics: Hepatitis, Hepatitis B, Virus, Virology

Read More →

Better Buy: Eli Lilly Vs. Glaxosmithkline

Eli Lilly (NYSE: LLY) and GlaxoSmithKline (NYSE: GSK) are undergoing transformations. Both big drugmakers have launched multiple new products to drive future growth while simultaneously dealing with sagging sales of older drugs.The companies'...

Read More →

Roche's Flu Medicine Xofluza Meets Goal In Study On Kids

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AstraZeneca PLC (AZN): Free Stock Analysis Report GlaxoSmithKline plc (GSK): Free...
Related topics: Flu, Influenza (Flu), Medical Research, Astrazeneca

Read More →

Glaxo Presents Encouraging Data On Endometrial Cancer Drug

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock...
Related topics: Endometrial Cancer, Cancer, Oncology, Medical Research, Pfizer

Read More →

Better Buy: Glaxosmithkline Vs. Eli Lilly

If you haven't looked at GlaxoSmithKline (NYSE: GSK) and Eli Lilly (NYSE: LLY) in several years, you probably wouldn't recognize them today. Eli Lilly recently spun off its animal health segment, and Glaxo's merging its consumer health business with...

Read More →

Merck's Keytruda Gets Fda Priority Review For Head/neck Cancer

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report Merck & Co., Inc. (MRK): Get...
Related topics: Merck & Co, Food And Drug Administration, Cancer, Oncology, Medical Research

Read More →

Mylan's Generic Version Of Advair Diskus Wins Fda Approval

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report Novartis AG (NVS): Get Free...
Related topics: Food And Drug Administration, Medical Research, Novartis

Read More →

How To Save $650 Million Without Really Trying

When GlaxoSmithKline (NYSE: GSK) dropped out of the bidding process for Pfizer's (NYSE: PFE) consumer healthcare division, it appeared that Pfizer's only option was to spin off the segment as a new company.Apparently GlaxoSmithKline ultimately had...
Related topics: Pfizer

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.